Supplementary Table S1 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Luís Meza
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
221Publications signalées
3647Citations signalées
0Affiliations récentes
Domaines associés
Renal cell carcinoma treatmentCancer Immunotherapy and BiomarkersCAR-T cell therapy researchBladder and Urothelial Cancer TreatmentsCancer Genomics and Diagnostics
Publications récentes
Supplementary Figure S4 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Table S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S5 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S3 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S1 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S6 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma
Salvador Jaime‐Casas, Regina Barragán-Carrillo, Miguel Zugman, Koral Shah et autres
1 citationFrontiers in Oncology
27Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma
Benjamin Mercier, Ameish Govindarajan, Nathaniel Hansen, Sara A. Byron et autres
1 citationThe Oncologist
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma
Nicholas Salgia, Adil Khan, Wilhelm M. Aubrecht, Gavin C Twoey et autres
16 citationsCancer Cell
Genomic landscape and clinical characteristics of patients (pts) with neuroendocrine prostate cancer (NEPC) with or without aggressive variant prostate cancer characterized by molecular signature (AVPC-MS).
Hedyeh Ebrahimi, Regina Barragán-Carrillo, Miguel Zugman, Salvador Jaime‐Casas et autres
2 citationsJournal of Clinical Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.